This suggests that the Hp2-2 genotype’s role in GDM development is connected to its function in scavenging free Hb, indicating that targeting elevated Hb concentrations may be a viable therapeutic strategy for GDM prevention, tailored to Hp polymorphism. This evidence concerns the gene HP and gestational diabetes.